9th Microbiome Movement Drug Development Summit

Back for its 9th consecutive year and gathering over 250 leaders in the space, the Microbiome Movement Drug Development Summit is the largest meeting within the renowned Microbiome Movement conference series.

With the MHRA, Seres Therapeutics, Siolta Therapeutics, Maat Pharma, Rise Therapeutics, Freya Biosciences, EnteroBiotix, Genome & Co, Concerto Biosciences and Altimmune joining, this summit will help C-Level, business development, bioanalytical, R&D, clinical & CMC to equip teams with technical insight to expedite drug development and network with a community dedicated to proving the clinical utility of microbiome modalities.

Find Out More: https://ter.li/0hoz4r